Skip to main content
. 2016 Jan 29;3(1):5–8. doi: 10.18632/oncoscience.286

Figure 1. CDCP1-mediated and targetable pathways in cancer.

Figure 1

CDCP1 promotes cancer cell proliferation (generally under non-adherent conditions), survival and migration, and mediates resistance to chemo- and targeted-therapies. CDCP1 expression at the cell surface is increased by ligand activation of EGFR signaling, constitutively activated mutant Ras (Ras*), and hypoxia (O2↓). Scissors represent arginine/lysine specific serine proteases that cleave and activate CDCP1.